Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Lttl vs RxSpan MD

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #159
Lttl

Lttl (pronounced “little”) publishes its entire term ladder on one public page — every medication, route and commitment length, month-to-month rung included — alongside compounded semaglutide and tirzepatide, a low-dose microdose line and a longevity range.

Marked down on: One advertised figure is purchasable at no tier: every product card prints the same “from $129/mo”, including tirzepatide, whose own four rungs are $279, $249, $229 and $199

vs
Dispatch #12Desk pick
RxSpan MD

A physician-founded desk with one of the widest menus in the ranking — compounded and brand-name GLP-1 across injectable and oral routes, microdosing, plus longevity, hair, and sexual-health lines — with transparent, all-inclusive pricing across all 50 states.

Marked down on: Compounded semaglutide and tirzepatide are not FDA-approved — not the same as Wegovy/Ozempic or Zepbound

RxSpan MD takes this head-to-head with the higher Desk Score, 86/100 (B) against 66/100 (C) for Lttl. Lttl still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Lttl

66/100

C

Overall

RxSpan MD

86/100

B

Price transparency

78
90

State access

24
97

Molecule range

90
94

Onboarding speed

70
84

Support responsiveness

73
82

Licensing & trust

65
86

The spec sheet

FieldLttlRxSpan MD
Semaglutide$199/mo month-to-month (compounded injectable; oral ODT $229/mo; the advertised $129/mo is a $1,548 annual prepay)From $194/mo
Tirzepatide$279/mo month-to-month (compounded injectable; the $129/mo on its product card matches no tirzepatide tier — the cheapest is $199/mo on a $2,388 annual prepay)$329/mo
CoverageCoverage not publishedAll 50 states
Brand-nameYesYes
Oral optionYesYes
Best forShoppers who want to see every commitment tier priced before they hand over any details, and who want a low-dose microdose option next to the full-strength lines.Patients who want a broad, physician-led menu across GLP-1 routes and adjacent longevity care, with transparent all-inclusive pricing and nationwide reach.
Desk Score66/100C86/100B

The verdict

Desk pick — RxSpan MD

RxSpan MD takes this head-to-head with the higher Desk Score, 86/100 (B) against 66/100 (C) for Lttl. Lttl still holds its ground where its strengths line up with yours.

Choose Lttl if…

Shoppers who want to see every commitment tier priced before they hand over any details, and who want a low-dose microdose option next to the full-strength lines.

$199/mo month-to-month (compounded injectable; oral ODT $229/mo; the advertised $129/mo is a $1,548 annual prepay) sema · $279/mo month-to-month (compounded injectable; the $129/mo on its product card matches no tirzepatide tier — the cheapest is $199/mo on a $2,388 annual prepay) tirz · Coverage not published

Choose RxSpan MD if…

Patients who want a broad, physician-led menu across GLP-1 routes and adjacent longevity care, with transparent all-inclusive pricing and nationwide reach.

From $194/mo sema · $329/mo tirz · All 50 states

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Lttl · RxSpan MD.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.